InsiderTrades.com logo
Cash Holders STILL Aren't Taking Steps to Prepare
From Investor Place Media   |   Ad
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Click Here to Learn More

LIAN Insider Trading

Insider Ownership Percentage: 8.06%
Insider Buying (Last 12 Months): $2,733,039.00
Insider Selling (Last 12 Months): $0.00

LianBio Insider Trading History Chart

This chart shows the insider buying and selling history at LianBio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LianBio Share Price & Price History

Current Price: $2.43
Price Change: ▼ Price Decrease of -0.06 (-2.41%)
As of 02/1/2023 01:00 AM ET

This chart shows the closing price history over time for LIAN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

LianBio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2022Perceptive Advisors LlcDirectorBuy998,240$2.40$2,395,776.003,728,491View SEC Filing Icon  
5/25/2022Perceptive Advisors LlcDirectorBuy120,000$2.63$315,600.002,661,251View SEC Filing Icon  
5/23/2022Perceptive Advisors LlcDirectorBuy8,700$2.49$21,663.002,498,700View SEC Filing Icon  
See Full Table
Know Your Profit Potential BEFORE You Trade!
From Tradewins   |   Ad
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital.

Click here for a free copy now!
Click Here to Learn More
pixel

SEC Filings (Institutional Ownership Changes) for LianBio (NASDAQ:LIAN)

77.56% of LianBio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LIAN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

LianBio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Tybourne Capital Management HK Ltd.3,303,573$6.61M0.6%-0.3%3.049%Search for SEC Filing on Google Icon
11/15/2022Perceptive Advisors LLC57,558,451$115.12M3.3%+1.8%53.121%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD2,822,857$5.62M0.0%+32.7%2.605%Search for SEC Filing on Google Icon
11/15/2022Logos Global Management LP307,908$0.62M0.1%-21.9%0.284%Search for SEC Filing on Google Icon
11/15/2022Marshall Wace LLP206,497$0.41M0.0%-7.6%0.191%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.1,023,107$2.05M0.0%-0.9%0.944%Search for SEC Filing on Google Icon
11/14/2022Powell Investment Advisors LLC30,000$60K0.0%N/A0.028%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC315,000$0.63M0.0%+417.2%0.291%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 20,773$41K0.0%+1,695.4%0.019%Search for SEC Filing on Google Icon
11/7/2022TD Asset Management Inc.178,519$0.36M0.0%+15.2%0.165%Search for SEC Filing on Google Icon
11/3/2022The Manufacturers Life Insurance Company 117,484$0.24M0.0%+51.0%0.108%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC268,400$0.54M0.0%N/A0.248%Search for SEC Filing on Google Icon
10/18/2022Bailard Inc.19,606$39K0.0%-58.8%0.018%Search for SEC Filing on Google Icon
8/16/2022Thrivent Financial for Lutherans79,220$0.17M0.0%+60.0%0.073%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD2,126,878$4.59M0.0%-5.2%1.964%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC32,300$70K0.0%N/A0.030%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC837,173$1.81M0.0%+18.2%0.773%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC113,201$0.25M0.0%-39.6%0.105%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC60,900$0.13M0.0%+66.7%0.056%Search for SEC Filing on Google Icon
8/12/2022Affinity Asset Advisors LLC450,000$0.97M0.4%+38.5%0.416%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.64,228$0.14M0.0%-41.7%0.059%Search for SEC Filing on Google Icon
7/27/2022Bailard Inc.47,597$0.10M0.0%+29.0%0.044%Search for SEC Filing on Google Icon
5/17/2022Alyeska Investment Group L.P.339,242$1.26M0.0%+19.1%0.316%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.43,185$0.16M0.0%N/A0.040%Search for SEC Filing on Google Icon
5/16/2022Vident Investment Advisory LLC19,913$74K0.0%N/A0.019%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG33,491$0.12M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC36,524$0.14M0.0%N/A0.034%Search for SEC Filing on Google Icon
5/13/2022Affinity Asset Advisors LLC325,000$1.21M0.2%+348.9%0.303%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.533,795$1.98M0.0%N/A0.498%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.20,000$74K0.0%N/A0.019%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.36,900$0.14M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/25/2022Tybourne Capital Management HK Ltd.3,314,173$20.42M0.6%N/A3.090%Search for SEC Filing on Google Icon
2/15/2022Laurion Capital Management LP200,000$1.23M0.0%N/A0.186%Search for SEC Filing on Google Icon
2/14/2022Deerfield Management Company L.P. Series C1,782,747$10.98M0.2%N/A1.662%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC56,319,960$346.93M5.4%N/A52.518%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd19,957$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/14/2022Schf GPE LLC937,500$5.78M1.0%N/A0.874%Search for SEC Filing on Google Icon
2/14/2022Ghisallo Capital Management LLC100,000$0.62M0.0%N/A0.093%Search for SEC Filing on Google Icon
2/14/2022Alliancebernstein L.P.3,204,730$19.74M0.0%N/A2.988%Search for SEC Filing on Google Icon
2/14/2022Casdin Capital LLC206,415$1.27M0.0%N/A0.192%Search for SEC Filing on Google Icon
2/14/2022Affinity Asset Advisors LLC72,406$0.45M0.2%N/A0.068%Search for SEC Filing on Google Icon
2/11/2022CNA Financial Corp15,993$99K0.0%N/A0.015%Search for SEC Filing on Google Icon
2/11/2022Pentwater Capital Management LP110,000$0.68M0.0%N/A0.103%Search for SEC Filing on Google Icon
2/11/2022MYDA Advisors LLC20,000$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/10/2022Vida Ventures Advisors LLC2,282,084$14.06M5.3%N/A2.128%Search for SEC Filing on Google Icon
2/10/2022TD Asset Management Inc.154,919$0.95M0.0%N/A0.144%Search for SEC Filing on Google Icon
2/9/2022Element Capital Management LLC20,157$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.121,816$0.75M0.0%N/A0.114%Search for SEC Filing on Google Icon
2/7/2022Victory Capital Management Inc.173,460$1.07M0.0%N/A0.162%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
LianBio logo
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor for ulcerative colitis and Crohn's disease; NX-13 for ulcerative colitis; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03, an eye solution for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Read More on LianBio

Today's Range

Now: $2.43
Low: $2.40
High: $2.55

50 Day Range

MA: $1.91
Low: $1.26
High: $2.69

52 Week Range

Now: $2.43
Low: $1.07
High: $6.24

Volume

70,189 shs

Average Volume

304,384 shs

Market Capitalization

$263.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of LianBio?

LianBio's top insider shareholders include:
  1. Perceptive Advisors Llc (Director)
Learn More about top insider investors at LianBio.
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel